Data mining of multiple neuroblastoma gene expression datasets confirmed that ZRF1 mRNA expression was elevated in subsets of patients with the most common genetic alterations associated with poor outcomes, thereby supporting our initial hypothesis, although this correlation could not be confirmed at the protein level in neuroblastoma patient samples. Here, DNAJC2 is linked to neuroblastoma.